Knight Therapeutics (KHTRF) Q3 2024 Earnings

Aug 8Confirmed
Nov 2022
Q4 2023
Q2 2024
Q3 2024
-0.17
-0.11
-0.05
0.02

Details

Expected EPS
0.0173051681
Actual EPS
-0.014614
Surprise EPS
-0.03
Surprise Percent
-184.45%

Description

⁨Knight Therapeutics⁩ (⁦KHTRF⁩) has reported earnings of ⁦-0.014614⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts